Standard Chemical & Pharmaceutical Co Ltd (1720)

Currency in TWD
61.00
+1.50(+2.52%)
Closed·
Unusual trading volume
High dividend Yield
1720 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
59.5061.10
52 wk Range
51.2065.30
Key Statistics
Bid/Ask
38.70 / 38.75
Prev. Close
60.1
Open
59.5
Day's Range
59.5-61.1
52 wk Range
51.2-65.3
Volume
872.86K
Average Volume (3m)
235.05K
1-Year Change
-6.45%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1720 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
73.00
Upside
+19.67%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Standard Chemical & Pharmaceutical Co Ltd Company Profile

Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicine, cosmetics, beverage, normal instruments, and medical instruments. It also sells various medical supplements, as well as preventive medicine; and imports and exports various medical products, medicine, supplements, nourishment, and function food. In addition, the company is involved in wholesale of multi-function printers and information software; retail and wholesale of various medicines; manufacturing and sale of food; and research and development, manufacturing, and sale of APIs, biopesticide, fertiliser and biochemical nutrition. Its products are used for cardiovascular system, metabolic system, topical skin medication, genitourinary system and sex steroids, anti-infective drugs, respiratory system, musculoskeletal system, digestive system, nervous system, circulatory system, and other areas. The company was incorporated in 1967 and is headquartered in Tainan City, Taiwan.

Compare 1720 to Peers and Sector

Metrics to compare
1720
Peers
Sector
Relationship
P/E Ratio
11.9x0.0x−0.6x
PEG Ratio
2.210.000.00
Price/Book
1.8x0.0x2.6x
Price / LTM Sales
1.5x0.0x3.3x
Upside (Analyst Target)
22.7%0.0%41.3%
Fair Value Upside
Unlock0.0%4.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 73.00
(+19.67% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.00%
Dividend Yield
4.62%
Industry Median 2.49%
Annualised payout
2.80
Paid annually
5-Years Growth
+13.30%
Growth Streak

Earnings

Latest Release
Nov 10, 2025
EPS / Forecast
1.72 / 1.36
Revenue / Forecast
1.77B / 1.82B
EPS Revisions
Last 90 days

1720 Income Statement

People Also Watch

13.480
BKT
-1.82%
317.80
ESLX
-0.66%
77.575
ACS
-0.29%
104.64
NOVN
-1.04%
9.2790
SAN
-2.79%

FAQ

What Stock Exchange Does SCPC Trade On?

SCPC is listed and trades on the Taiwan Stock Exchange stock exchange.

What Is the Stock Symbol for SCPC?

The stock symbol for SCPC is "1720."

What Is the SCPC (1720) Afterhours Price Today? (Afterhours variable test: 0.00) Current Date: 14 Nov 2025

After hours price: 0.00. After hours price change (units): 0.00. Price change percentage: 0.00%

What Is the SCPC Market Cap?

As of today, SCPC market cap is 10.63B.

What Is SCPC's Earnings Per Share (TTM)?

The SCPC EPS (TTM) is 5.00.

When Is the Next SCPC Earnings Date?

SCPC will release its next earnings report on 03 Mar 2026.

From a Technical Analysis Perspective, Is 1720 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has SCPC Stock Split?

SCPC has split 9 times.

What is the current trading status of SCPC (1720)?

As of 14 Nov 2025, SCPC (1720) is trading at a price of 61.00, with a previous close of 60.10. The stock has fluctuated within a day range of 59.50 to 61.10, while its 52-week range spans from 51.20 to 65.30.

What Is SCPC (1720) Price Target According to Analysts?

The average 12-month price target for SCPC is TWD73, with a high estimate of TWD73 and a low estimate of TWD73. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +19.67% Upside potential.

What Is the 1720 After Hours Price?

1720's last after hours stock price is 0.00, the stock has decreased by 0.00, or 0.00%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.